The meditation app developer has quadrupled its valuation to $1bn in just eight months, in an $88m series B round featuring CAA.
Month: February 2019
Alector achieves $176m IPO
The AbbVie, Eli Lilly, Amgen, Merck & Co and Alphabet-backed neurodegenerative disease drug developer is floating in the middle of its range.
VArmour secures $44m in series E round
The data centre and cloud security software provider, which is backed by Telstra and Citi, has increased its funding to $127m altogether.
Aetion advances series B past $63m
Sanofi, UCB, Horizon Health Services and McKesson Ventures added $27m to a series B round for the medical data software provider that already included Amgen Ventures.
Ola takes extra series J fare
On-demand ride platform Ola has added $15.3m to a round that now totals about $160m, though none of its corporate investors have so far contributed.
Healthy.io takes home $18m
Samsung Next has taken part in a series B round that will fund the roll out of Healthy.io’s home urinalysis analyser system in the UK and expansion in the US.
Vinli makes tracks with Eon-backed series B
The automotive data platform developer, which counts Samsung, Cox Enterprises and Continental as shareholders, has secured $13.5m in its series B round.
Mobidiag mobilises Autobio investment
The molecular diagnostics equipment provider has completed a $11.3m investment from China-based Autobio Diagnostics that was announced in December.
Reddit readies $300m series D round
Tencent is in talks to invest $150m in Reddit, an online social platform backed by Condé Nast, as part of a series D round that could reach $300m and value it at $3bn.
Zomato increases latest serving to $250m
Glade Brook Capital has invested $39.7m in food listings and ordering platform Zomato, adding to $210m from Ant Financial in October.
Raisin puts $114m in its account
PayPal followed an investment in 2017 by participating in a series D round for the cross-border savings platform that will fund geographic expansion.
Bolt hits series B with $54m
Nan Fung Life Sciences and Novo have taken part in the immuno-oncology drug developer’s series B round, which was led by Pivotal BioVenture Partners.
Personal Capital puts hands on $50m
The BBVA and USAA-backed digital wealth manager has now raised about $265m altogether, after scoring $50m in a series F round led by IGM Financial.
Signal Sciences picks up $35m
O’Reilly Media has taken part in the cybersecurity company’s series C round, which was led by Lead Edge Capital, boosting its overall funding to nearly $62m.